Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Journal of the American College of Cardiology|February 24, 2009
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance"Francesca Santilli, Bianca Rocca, Raimondo De Cristofaro, et al.
Circulation. Genomic and Precision Medicine|February 17, 2018
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE StudySarah Parish, Jemma C Hopewell, Michael R Hill, et al.
Clinical Kidney Journal|December 8, 2018
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY studyWilliam G Herrington, David Preiss, Richard Haynes, et al.
Kidney International|November 18, 2017
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammationBenjamin C Storey, Natalie Staplin, Richard Haynes, et al.
European Heart Journal|July 24, 2020
Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptomJemma C Hopewell, Alison Offer, Richard Haynes, et al.
Kidney International|February 4, 2018
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapyBenjamin C Storey, Natalie Staplin, Charlie H Harper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 25, 2015
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)Borislava Mihaylova, Iryna Schlackow, William Herrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal ProtectionWilliam Herrington, Jonathan Emberson, Natalie Staplin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 31, 2023
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization StudyKillian Donovan, William G Herrington, Guillaume Paré, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2025
Aspirin inhibition and recovery of cyclooxygenase activity and thromboxane biosynthesis in human megakaryocytes: a translational surrogate modelZahraa I Mallah, Giovanna Petrucci, Abeer J Ayoub, et al.
Pageof 20